(Q53558733)

English

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

Bennett P. deBoisblanc

3

object named as

B P deBoisblanc

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

author name string

H S Nelson

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

W W Busse

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

W E Berger

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

M J Noonan

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

D R Webb

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

J P Wolford

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

P S Mahajan

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

A G Hamedani

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

T Shah

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

S M Harding

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

number of pages

9

1 reference

based on heuristic

inferred from page(s)

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

103

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

2 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

267-275

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of long-term steroid therapy for asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis and treatment of steroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Auranofin in the treatment of steroid dependent asthma: a double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate in the treatment of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of steroid-dependent bronchial asthma with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970501-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0091-6749(99)70501-4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9949318

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53558733&oldid=1902776325"